产品编号:F1038-1
产品描述:Recombinant Rat Fractalkine(FKN)
反应种属:
实验方法:
标记:
规格:1mg
供应商:Leinco
价格(RMB):面议
订购:
说明书:
Recombinant Rat Fractalkine(FKN)
Purified No Carrier Protein
(CX3CL1, NTN, ABCD-3, C3Xkine, CXC3, CXC3C, NTT, SCYD1, Neurotactin, FKN)
Prod. No.: F1038
Source E. coli
Pkg. Size: 1 mg, 25 µg
Storage: -20°C to -70°C
Description
Background:
Fractalkine (FKN) is a transmembrane mucin-chemokine hybrid molecule expressed on activated endothelium1 that mediates attachment and firm adhesion of T cells, monocytes and NK cells.2 FKN plays an important proinflammatory role in rheumatoid arthritis (RA) pathogenesis as characterized by induction of synovial angiogenesis, chemotaxis, activation of monocytes and T cells as well as the stimulation of proliferation and synthesis of matrix degrading enzymes (matrix metalloproteinases, MMP) in synovial fibroblasts. Fractalkine thus may represent a novel target molecule for therapeutic intervention in RA.3 FKN is also an essential biomarker for predicting the prognosis of patients with colorectal cancer (CRC).4
Source
E. coli
Molecular Weight
The predicted molecular weight of Recombinant Rat Fractalkine is Mr 8.8 kDa.
State of Matter
Lyophilized
Purity
>97% by SDS Page and analyzed by silver stain.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Endotoxin
<1.0 EU/µg as determined by the LAL method
Biological Activity
The biological activity of Rat FKN was determined by its ability to chemoattract freshly isolated human peripheral blood lymphocytes (PBL). The expected ED50 is 0.003 - 0.009 µg/ml.
Each investigator should determine their own optimal working dilution for specific applications.
Amino Acid Sequence
Gln25 - Gly100
References
1. Patel DD et al. (1998) J Exp Med. 188: 1413
2. Hwang ST et al. (1999) Eur J Immunol. 29: 2551
3. Muller GA et al. (2008) Z Rheumatol. 67: 424
4. Mori M et al. (2005) Int J Oncol. 26: 41
Related Products
Recombinant Human Fractalkine (CX3CL1) (Leinco Prod. No.: F116)
Anti-Human Fractalkine (Antigen Aff. Pur.) (Leinco Prod. No.: F120)
Anti-Human Fractalkine (Leinco Prod. No.: C1306)
Recombinant Rat Fractalkine (Leinco Prod. No.: F1023)
Recombinant Human Fractalkine (CX3CL1) (Leinco Prod. No.: F1030)
Recombinant Mouse Fractalkine (Leinco Prod. No.: F1035)
Recombinant Mouse Fractalkine (Leinco Prod. No.: F1036)
Recombinant Mouse Fractalkine (Fragmented) (Leinco Prod. No.: F1040)
Anti-Human Fractalkine (Leinco Prod. No.: C1405)
Anti-Human Fractalkine (Leinco Prod. No.: C1406)
Anti-Rat Fractalkine (Leinco Prod. No.: C1438)
Anti-Mouse Fractalkine (Leinco Prod. No.: C1442)
Anti-Rat Fractalkine (Antigen Aff. Pur.) (Leinco Prod. No.: C1467)
Anti-Human Fractalkine-Biotin (Antigen Aff. Pur.) (Leinco Prod. No.: C1492)
Anti-Rat Fractalkine-Biotin (Antigen Aff. Pur.) (Leinco Prod. No.: C1512)
Anti-Human Fractalkine-Biotin (Antigen Aff. Pur.) (Leinco Prod. No.: F136)
Anti-Mouse Fractalkine (Antigen Aff. Pur.) (Leinco Prod. No.: F1069)
Anti-Mouse Fractalkine-Biotin (Antigen Aff. Pur.) (Leinco Prod. No.: F1098)
